Physician profile
Patrick T Roughneen
NPI 1205847936
$8,347.47
in general payments reported to CMS, 2019-2025
18 companies · $464 in 2025
The $464 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,812 · 2020: $136 · 2021: $52.04 · 2022: $558 · 2023: $2,021 · 2024: $305 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,615 · Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,615.02 |
| Food and Beverage | $1,174.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,002.16 | 2019-2020 | |
| Philips North America LLC | $1,256.33 | 2022-2023 | |
| Abbott Laboratories | $1,180.82 | 2019-2021 | |
| Atricure, INC. | $1,096.11 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Abiomed | $953.16 | 2019-2025 | Impella |
| Medtronic, INC. | $217.99 | 2022-2025 | Endurant Iis, Hawkone, Avalus |
| Edwards Lifesciences Corporation | $176.74 | 2020-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $128.06 | 2024-2025 | Barostim Neo System |
| Ethicon US, LLC | $82.75 | 2023-2025 | Stratafix, Vistaseal, Prolene |
| Astrazeneca Pharmaceuticals Lp | $64.31 | 2022 | |
| On Target Laboratories, INC | $54.71 | 2025 | Cytalux |
| Baxter Healthcare | $31.25 | 2024 | Perclot |
| Bolton Medical INC | $23.48 | 2024 | Treo Abdominal Stent-Graft System |
| Livanova USA, INC. | $21.77 | 2023 | Protekduo |
| Davol INC. | $19.87 | 2025 | Arista |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $19.27 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $15.67 | 2021 | |
| Hemosonics LLC | $3.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Roughneen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.